Jing Yang

PhD, Molecular Biology and Biochemistry, East China University of Science and Technology & Shanghai Institutes for Biological Sciences of Chinese Academy of Sciences

Jing Yang’s research work is focused on revealing the relationships between genotype and immunophenotype and identifying the determinates of immunogenicity for immunotherapy in melanoma. Dr. Yang also studies the TGFβ signaling pathway that functions through SMAD4 in inflammation-associated cancer.

VUMC Reporter feature: Vanderbilt biostatisticians launch Cancer-Immu data portal for predicting response to immune checkpoint blockade immunotherapy